It's a bird in the hand.

They were being nickel-and-dimed by J&J. They had to get out of that loop.

They might have passed the acid test of being too big.

I think they easily could go up to $76 without a lot of damage.

I don't believe these things are going to matter for Boston Scientific. This is a strategic deal for them and these are small perturbations along the way.

I think they (St. Jude) definitely look like they are in play. They certainly would be an attractive candidate.